Oxford University Starts Research on MarijuanaApril 6, 2017
Researchers at Oxford University and Oxford Cannabinoid Technologies started a new study on understanding the potential of marijuana to treat different diseases such as cancer and chronic pain. The initial funding of £10 million from Kingsley Capital Partners, a London-based venture capital firm, will be used to identify new medical therapies through research on the molecular, cellular, and systems mechanisms of cannabinoids. At present, marijuana is not yet legal in the U.K.
"Cannabinoid research has started to produce exciting biological discoveries and this research program is a timely opportunity to increase our understanding of the role of cannabinoids in health and disease. This field holds great promise for developing novel therapeutic opportunities for cancer patients," said Ahmed Ahmed, Professor of Gynaecological Oncology at Oxford.
"Medical cannabis and cannabinoid medicine is already helping patients with some of the most distressing conditions across the world. However, research into the specific pathways and mechanisms that create this benefit is limited and long overdue. Through OCT, we hope our strategic partnership with Oxford will support the development of innovative new therapies to help millions of people around the world. The partnership gives the UK a global leadership role in this fast-growing field," said Neil Mahapatra, Managing Partner of Kingsley.
Aside from the conduct of research, Oxford and Kingsley will also host an International Cannabinoid Biomedicine Conference in the fourth quarter of 2017 to increase the dialogue in the cannabinoid research space.
Read the press release from Oxford University.
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
News from Around the World
- Parliamentary Journalists Support Dialogue on the Biotech and Biosafety Bill Passage in Uganda
- Kenyan Youth Farmers Call for Adoption of WEMA Bt Maize
- Senegal Ready for GMOs, Says President Macky Sall
- Researchers Reveal Family Tree of Microorganisms Responsible for Photosynthesis
- Survey Reveals 90% of Rural Producers in Brazil Recognize Importance of Biotechnology
- Scientists Develop GE Rice that Flower on Demand
- Oxford University Starts Research on Marijuana
- Chitinase Gene Confers Enhanced Resistance Against Rice Sheath Blight
- Gm1-MMP Enhances Tolerance to High Temperature and Humidity in Arabidopsis
Beyond Crop Biotech
- USDA Scientists Use Biotech Tools to Improve Guayule Plant As Natural Source of Tire Rubber
- Overexpression of AtSHN1 in Mulberry Reduces Postharvest Water Loss in Leaves
- The Petri Dish is Now Online
- Are GMOs Good or Bad? Genetic Engineering & Our Food
- Rapid Breeding of Parthenocarpic Tomato using CRISPR-Cas9
- CRISPR-Cas9 and -Cpf1-mediated Editing of the Stomatal Development Gene in Rice
Read the latest:
- Biotech Updates (November 29, 2023)
- Gene Editing Supplement (November 29, 2023)
- Gene Drive Supplement (February 22, 2023)
Subscribe to BU: